DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products ...

The upcoming report from DexCom (DXCM) is expected to reveal quarterly earnings of $0.33 per share, indicating an increase of 3.1% compared to the year-ago period. Analysts forecast revenues of $1 ...